China To Unveil Health Care Reform Plan Soon
This article was originally published in PharmAsia News
China's health care reform plan will be announced soon after the National People's Congress and National Committee of the Chinese People's Political Consultative Conference meetings, the Minister of Health revealed recently. RMB 850 billion will be allocated for the reform over the next three years, and a three-year pilot plan will be launched. As for the controversial hospital adjustment fee, the minister expressed that the policy will not take a one-size-fits-all approach for the different regions. He stressed that the goal of health care service price reform is to reduce the current high costs of drugs, medical consumables and diagnostics, while appropriately raising the technical fees and service charges of medical personnel. (Click here for more - Chinese Language)
You may also be interested in...
Facing soaring legal costs stemming from its failed merger with Fresenius Kabi and burdened by substantial debt, Akorn elected to put itself up for sale earlier this year in order to help repay lenders. But the company has now defaulted on an agreement with its creditors after no bidder stepped up to the plate.
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Following the announcement in the US that ranitidine drugs must be withdrawn from the market, the European Medicines Agency told the Pink Sheet it would decide on the fate of these medicines in the EU after wrapping up its own inquiry.